ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Hovione Acquires Finished-Drug Plant

by Michael McCoy
October 19, 2015 | APPEARED IN VOLUME 93, ISSUE 41

The pharmaceutical chemical producer Hovione is moving downstream in the production chain with the $10 million purchase of a finished-drug plant near its headquarters in Loures, Portugal. The plant was built by Sanofi predecessor Aventis and recently owned by a generic drug firm. The purchase is the second recent investment for Hovione. Earlier this month the company said it will spend $25 million at its East Windsor, N.J., facility to double chemical production and enhance spray-drying capability.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment